Integra adds upper extremity strength with Ascension buy
This article was originally published in Clinica
Integra LifeSciences has agreed to acquire Ascension Orthopedics for $65m in an all-cash deal that would add a "significant" upper extremity and shoulder portfolio to its existing lower extremity offering. Austin, Texas-based Ascension develops and distributes a range of implants for the shoulder, elbow, wrist, hand, foot and ankle. Its lower extremity products will enhance Integra's current line of foot and ankle devices, the company says. When combined, Ascension's products will account for approximately 45% of revenue generated by Integra's orthopaedics business segment, according to the companies.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.